Celebrex Proposed “Black Box” Could Be Removed With Safety Data – Cmte.

Pfizer should have the opportunity to get a proposed Celebrex COX-2 class cardiovascular "black box" warning removed from labeling if the company is able to demonstrate safety in post-marketing safety studies, an FDA advisory committee said